Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Casesfetal-neonatal-and-perinatal

Paeds Cases · fetal-neonatal-and-perinatal

Neonatal hypotonia and neuromuscular weakness — structured clinical encounter

Structured encounter testing the approach to a weak, areflexic, alert infant with spinal muscular atrophy: the central/peripheral split, the genetic confirmation, and the timing and evidence of disease-modifying therapy.

structured clinical encounter2 min readVerification in progress

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A 3-month-old former term infant presents with progressive floppiness, symmetric proximal weakness, tongue fasciculations and absent reflexes, alert and socially engaged. You are the neonatal registrar working through the bedside split, the genetic confirmation and the disease-modifying therapy with the team.

Station brief (candidate)

You are the neonatal registrar. A 3-month-old former term infant is referred with progressive floppiness, symmetric proximal weakness, tongue fasciculations and absent deep tendon reflexes. Between episodes the infant is alert and socially engaged. The creatine kinase is normal. The team asks you to make the bedside diagnosis, arrange the confirming test, and outline the disease-modifying therapy and its timing. You have 12 minutes with the team and 5 minutes for examiner discussion. [10]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Finkel RS; Mercuri E; Darras BT; Connolly AM; et al Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. N Engl J Med, 2017.PMID 29091570
  2. [2]Strauss KA; Farrar MA; Muntoni F; Saito K; et al Onasemnene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nat Med, 2022.PMID 35715567
  3. [3]Mercuri E; Finkel RS; Muntoni F; Wirth B; et al Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord, 2018.PMID 29290580
  4. [5]Glascock J; Sampson J; Haidet-Phillips A; Connolly A; et al Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening. J Neuromuscul Dis, 2018.PMID 29614695
  5. [9]Ostojić S; Kovačević G; Meola G; Pešović J; et al Main features and disease outcome of congenital myotonic dystrophy - experience from a single tertiary center. Neuromuscul Disord, 2024.PMID 38810326
  6. [10]Bodensteiner JB The evaluation of the hypotonic infant. Semin Pediatr Neurol, 2008.PMID 18342256
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNeonatal gastro-oesophageal reflux and aspiration — clinical casefetal-neonatal-and-perinatalNextNeonatal jaundice: unconjugated hyperbilirubinaemia: Casefetal-neonatal-and-perinatal